Successful paroxetine treatment of major depression in an adult form of metachromatic leukodystrophy with cognitive disturbances.
G
G
Vella
C
C
Loriedo
R
R
Raccah
P
P
Baldassarre
A
A
Paolillo
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000150:complications*; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007966:Leukodystrophy, Metachromatic / Q000150:complications*; D017374:Paroxetine / Q000627:therapeutic use*; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
D018687:Antidepressive Agents, Second-Generation; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors